Related Experiment Videos
[Hypophyseal gammography in man. Preliminary report]
La Prensa Medica Mexicana
|July 1, 1975
Summary
This study explored using radioactive iodine-131 estrogenic complex for pituitary scans. The non-invasive oral method showed no toxicity and visualized the pituitary gland effectively in patients and healthy volunteers.
Area of Science:
- Nuclear Medicine
- Endocrinology
- Radiopharmacology
Context:
- Pituitary adenomas require accurate diagnostic imaging.
- Current pituitary imaging methods may have limitations or invasiveness.
- Estrogenic compounds can target pituitary tissue.
Purpose:
- To evaluate the safety and efficacy of an estrogenic complex labeled with iodine-131 (131-I) for pituitary imaging.
- To assess the potential of this radiopharmaceutical for non-invasive visualization of the pituitary gland.
Summary:
- Two healthy volunteers and one patient with pituitary adenoma underwent oral administration of 400 muCi of 131-I estrogenic complex.
- Pituitary imaging was performed 24 hours post-ingestion.
- The study observed no toxic reactions (clinical or laboratory) over a three-month follow-up period.
- Direct, non-invasive visualization of the pituitary gland was achieved with a single oral dose.
Impact:
- This novel radiotracer shows promise for safe and effective pituitary gland imaging.
- The non-invasive oral administration simplifies the diagnostic procedure.
- Further research is warranted to fully establish the clinical utility of this imaging agent.